FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely gastroenterology, and may be used for treating the patients with the first stage cholelithiasis. That is ensured by administering the preparation Mucofalc 1 sachet 3 times a day for 22-24 weeks.
EFFECT: method enables extending the range of drug preparations having litholytic action in the first stage cholelithiasis with no side effects.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PROPHYLAXIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CHOLELITHIASIS AFTER LAPAROSCOPIC CHOLECYSTECTOMY | 2017 |
|
RU2657838C1 |
| METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
| WAY OF MEDICAMENTAL CORRECTION OF 2 STAGE OF CHOLELITHIASIS AT PATIENTS WITH OPISTHORCHOSIS | 2008 |
|
RU2362564C1 |
| METHOD OF CONSERVATIVE TREATMENT OF LITHIC STAGE OF CHOLELITHIASIS | 2012 |
|
RU2490017C1 |
| METHOD FOR STUDYING BILE ACIDS AND CHOLESTEROL METABOLISM | 2004 |
|
RU2260184C1 |
| DIAGNOSTIC TECHNIQUE FOR EARLY CHOLELITHIASIS IN PATIENTS WITH OPISTHORCHIASIS | 2009 |
|
RU2420741C2 |
| METHOD OF TREATING PATIENTS SUFFERING FROM CHOLELITHIASIS FOLLOWING GALL BLADDER SURGERIES | 2013 |
|
RU2519364C1 |
| METHOD FOR TREATING CHOLELITHIASIS PATIENTS FOR HYPERCHOLESTEROLEMIA STATES BY ADMINISTERING HEPATOSAN PREPARATION ACCELERATING CHOLESTEROL OXIDATION IN LIVER | 2006 |
|
RU2306943C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CHOLELITHIASIS, CHOLESTEROSIS AND GALL BLADDER POLYPS | 2008 |
|
RU2367353C1 |
| METHOD FOR BILIARY SLUDGE TREATMENT IN PATIENTS WITH CHRONIC BILIAR-DEPENDENT PANCREATITIS | 2016 |
|
RU2632443C1 |
